ipilimumab
bms
['melanoma']
excited to have seen the results presented of the positive phase 3 til trial at esmo 2022 #esmo2022 #cancerresearch #melanoma 
The Netherlands Cancer Institute (NKI): at the international forefront of cancer research and treatment for over 100 years. Our Dutch account is @hetAVL.